APA (7th ed.) Citation

J, C., TS, M., K, N., R, R., KH, L., MR, M., . . . YL, W. (2019). Effects of dose modifications on the safety and efficacy of dacomitinib for EGFR mutation-positive non-small-cell lung cancer. Future oncology (London, England), 15(24), 2795. https://doi.org/10.2217/fon-2019-0299

Chicago Style (17th ed.) Citation

J, Corral, et al. "Effects of Dose Modifications on the Safety and Efficacy of Dacomitinib for EGFR Mutation-positive Non-small-cell Lung Cancer." Future Oncology (London, England) 15, no. 24 (2019): 2795. https://doi.org/10.2217/fon-2019-0299.

MLA (9th ed.) Citation

J, Corral, et al. "Effects of Dose Modifications on the Safety and Efficacy of Dacomitinib for EGFR Mutation-positive Non-small-cell Lung Cancer." Future Oncology (London, England), vol. 15, no. 24, 2019, p. 2795, https://doi.org/10.2217/fon-2019-0299.